Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method

TLDR

The Chou‑Talalay method uses a median‑effect equation derived from the mass‑action law, unifying single‑ and multi‑entity pharmacodynamics and encompassing classic biochemical models such as Michaelis‑Menten and Hill. The article reviews common errors and best practices in drug‑combination studies across design, data acquisition, interpretation, and simulation. Chou‑Talalay’s CI theorem quantitatively defines additive, synergistic, and antagonistic effects and supplies algorithms for automated simulation of these interactions via CI plots and isobolograms. Cancer Research 70(2): 440–446.

Abstract

Abstract This brief perspective article focuses on the most common errors and pitfalls, as well as the do's and don'ts in drug combination studies, in terms of experimental design, data acquisition, data interpretation, and computerized simulation. The Chou-Talalay method for drug combination is based on the median-effect equation, derived from the mass-action law principle, which is the unified theory that provides the common link between single entity and multiple entities, and first order and higher order dynamics. This general equation encompasses the Michaelis-Menten, Hill, Henderson-Hasselbalch, and Scatchard equations in biochemistry and biophysics. The resulting combination index (CI) theorem of Chou-Talalay offers quantitative definition for additive effect (CI = 1), synergism (CI < 1), and antagonism (CI > 1) in drug combinations. This theory also provides algorithms for automated computer simulation for synergism and/or antagonism at any effect and dose level, as shown in the CI plot and isobologram, respectively. Cancer Res; 70(2); 440–6